• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Zepbound

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp store in Las Vegas Nevada on February 7 2024
Favicon Fierce Pharma

CVS will cover Eli Lilly obesity products Zepbound and Foundayo

CVS will restore coverage to obesity products from Eli Lilly, allowing patients to gain access to the drugs through their existing insurance.
Kevin Dunleavy May 28, 2026 11:20am
Ozempic Wegovy

Him & Hers now offers all FDA-approved GLP-1s

Apr 23, 2026 10:43am
vial of Zepbound obesity drug
Favicon Fierce Pharma

Lilly lowers self-pay prices of single-dose Zepbound vials

Dec 1, 2025 8:00am
White House
Favicon Fierce Pharma

Lilly, Novo reach GLP-1 pricing deals with White House

Nov 6, 2025 12:26pm
weight loss scale weigh measure tape obesity overweight
Favicon Fierce Pharma

Novo, Lilly obesity meds 'highly cost-effective': ICER report

Sep 9, 2025 10:30am
Zepbound tirzepatide

CVS hit with lawsuit over dropping Zepbound from formulary

Sep 5, 2025 4:58pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings